Home Logon FTA Investment Managers Blog Subscribe About Us Contact Us

Search by Ticker, Keyword or CUSIP       
 
 
 
Strategic International Opportunity, 22 (Terminated)   Ticker: FYDQOX
 
 Trust Performance  (as of 9/11/2023) *Inception Date is 6/10/2022 
  Cumulative Total Return Average Annual Total Return
  YTD Since
Inception*
3 mo 6 mo 1 yr 3 yr 5 yr 10 yr Since
Inception*
Distributions Reinvested
With Transactional
Sales Charge
9.71%  6.87%  -0.71%  4.73%  12.61%  N/A  N/A  N/A  5.44% 
Without Transactional
Sales Charge
11.21%  8.34%  0.65%  6.16%  14.15%  N/A  N/A  N/A  6.59% 
Distributions Received in Cash
With Transactional
Sales Charge
9.71%  6.81%  -0.71%  4.72%  12.54%  N/A  N/A  N/A  5.39% 
Without Transactional
Sales Charge
11.21%  8.27%  0.65%  6.16%  14.08%  N/A  N/A  N/A  6.54% 
 
MSCI AC WORLD EX US NET DIV TR(NDUEACWZ) 7.98%  5.89%  -0.71%  3.95%  11.54%  N/A  N/A  N/A  4.67% 


 Performance Calculator
 From Date: 
To Date: 
  Cumulative
Total Return
Average Annual
Total Return
With Transactional Sales Charge (Distributions Reinvested) 6.87%    5.44%   
Without Transactional Sales Charge (Distributions Reinvested) 8.34%    6.59%   
With Transactional Sales Charge (Distributions Received in Cash) 6.81%    5.39%   
Without Transactional Sales Charge (Distributions Received in Cash) 8.27%    6.54%   
MSCI AC WORLD EX US NET DIV TR(NDUEACWZ) 5.89%    4.67%   


Sales Charges (based on a $10 public offering price)
Standard Accounts
Transactional Sales Charges: Initial: 0.00%
  Deferred: 1.35%
Creation & Development Fee:   0.50%
Maximum Sales Charge:   1.85%
 
Fee/Wrap Accounts
Creation & Development Fee: 0.50%
Maximum Sales Charge: 0.50%
The table above shows the initial offering period sales charge. Certain performance periods shown on this page may begin after the end of the initial offering period and reflect a secondary market sales charge. Please see the prospectus for sales charge details, including the secondary market sales charge amount applicable to a period.

Past Performance is no indication of future results. Investment returns and principal value will fluctuate and units when sold or redeemed, may be worth more or less than their original cost. All returns are historical and do not represent potential future performance. This report is not and should not be construed as an offer to buy or sell securities.

Unless an index is indicated to be a price only index, all index returns assume that dividends are reinvested when they are received.

Returns With Transactional Sales Charge reflect the maximum transactional sales charge that would be payable by an investor upon sale or redemption of units at the end of the applicable period(s). The transactional sales charge includes any initial or deferred sales charges other than the creation and development fee. These returns do not reflect any creation and development fee prior to collection (generally the close of the initial offering period). Any creation and development fee is reflected in the returns as of the time of payment by a trust.

Returns Without Transactional Sales Charge do not reflect any transactional sales charge and do not reflect any creation and development fee prior to collection (generally the close of the initial offering period). Any creation and development fee is reflected in the returns as of the time of payment by a trust.

If applicable, returns shown with distributions reinvested assume distributions are reinvested on the reinvestment date.

Risk Considerations

Equity Risk. An investment in a portfolio containing common stocks is subject to certain risks, such as an economic recession and the possible deterioration of either the financial condition of the issuers of the equity securities or the general condition of the stock market.

Sector Concentration Risk. A portfolio which is concentrated in an individual sector is subject to additional risks, including limited diversification.

Brexit Risk. The United Kingdom's official departure from the European Union (commonly referred to as "Brexit") led to volatility in global financial markets, in particular those of the United Kingdom and across Europe, and the weakening in political, regulatory, consumer, corporate and financial confidence in the United Kingdom and Europe. It is not currently possible to determine the extent of the impact that Brexit may have on the portfolio's investments and this uncertainty could negatively impact current and future economic conditions in the United Kingdom and other countries, which could negatively impact the value of the portfolio's investments.

Consumer Products Risk. The companies engaged in the consumer products sector are subject to global competition, changing government regulations and trade policies, currency fluctuations, and the financial and political risks inherent in producing products for foreign markets.

Emerging Markets Risk. Risks associated with investing in non-U.S. securities may be more pronounced in emerging and developing markets where the securities markets are substantially smaller, less developed, less liquid, less regulated, and more volatile than the U.S. and developed non-U.S. markets.

Europe Concentration Risk. Because the portfolio is concentrated in companies headquartered or incorporated in Europe, the portfolio may present more risks than a portfolio which is broadly diversified over several regions.

Foreign Securities Risk. Securities of non-U.S. issuers are subject to additional risks, including currency fluctuations, political risks, withholding, the lack of adequate financial information, and exchange control restrictions impacting non-U.S. issuers.

Large-Cap Risk. Large capitalization companies may grow at a slower rate than the overall market.

Market Disruption Risk. Ongoing armed conflicts between Russia and Ukraine in Europe and among Israel, Hamas and other militant groups in the Middle East, have caused and could continue to cause significant market disruptions and volatility within the markets in Russia, Europe, the Middle East and the United States. The hostilities and sanctions resulting from those hostilities could have a significant impact on certain investments as well as performance.

Public Health Crisis Risk. A public health crisis, and the ensuing policies enacted by governments and central banks in response, could cause significant volatility and uncertainty in global financial markets, negatively impacting global growth prospects.

Small-Cap and Mid-Cap Risk. An investment in a portfolio containing small-cap and mid-cap companies is subject to additional risks, as the share prices of small-cap companies and certain mid-cap companies are often more volatile than those of larger companies due to several factors, including limited trading volumes, products, financial resources, management inexperience and less publicly available information.

Volatility Risk. The value of the securities held by the trust may be subject to steep declines or increased volatility due to changes in performance or perception of the issuers.

Operational Risk. As the use of Internet technology has become more prevalent in the course of business, the trust has become more susceptible to potential operational risks through breaches in cybersecurity.

This product information does not constitute an offer to sell, or a solicitation of an offer to buy securities in any state to any person to whom it is not lawful to make such an offer. Sales of any of these securities must include prospectus delivery and the services of a retail broker/dealer duly licensed in the appropriate states.

Not FDIC Insured, Not Bank Guaranteed and May Lose Value.

CUSIP identifiers have been provided by CUSIP Global Services, managed on behalf of the American Bankers Association by FactSet Research Systems Inc. and are not for use or dissemination in a manner that would serve as a substitute for any CUSIP service. The CUSIP Database, ©2024 CUSIP Global Services. "CUSIP" is a registered trademark of the American Bankers Association.

Fund Cusip Information
30326Y323 (Cash)
30326Y331 (Reinvest)
30326Y349 (Cash-Fee)
30326Y356 (Reinvest-Fee)
Printer Friendly Page Printer Friendly Page
 
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
Follow First Trust:  
First Trust Portfolios L.P.  Member SIPC and FINRA. (Form CRS)   •  First Trust Advisors L.P. (Form CRS)
Home |  Important Legal Information |  Privacy Policy |  California Privacy Policy |  Business Continuity Plan |  FINRA BrokerCheck
Copyright © 2024 All rights reserved.